Brain Metastases in Norway - A Prospective Cohort Study

University of Oslo (UIO)

Status: Active, not recruiting

Conditions: Brain Metastases

Study type: Observational

Funder types: Other

Identifiers

NCT03346655

2017/1358

Details and patient eligibility

About

The overall aim and primary outcome of this study will be a descriptive analysis of the current treatment practice of BM in Norway. Specifically, it may give answers to the following research questions:

• What is the true incidence of BM in Norway?
• How are patients with BM treated at present?
• Do treatments differ between hospitals?
• How do treatments impact quality of life of the patients?
• Which factors (treatment, tumor and host variables) can explain disease control, survival, symptom relief, and general functions?
• How can BM staging be improved?

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Verified cancer diagnosis of solid tumors (based on radiological, histological/cytological or operative evidence).
• Brain metastases verified by computer tomography (CT), contrast-enhanced magnetic resonance imaging (MRI), or surgical biopsies
• Age ≥ 18 years
• Able to comply with study procedures
• Able to provide written informed consent after information in Norwegian

Exclusion criteria

• Primary brain tumors
• Primary hematological malignancies (lymphomas, leukemias)
• Previous diagnosis and/or treatment of BM
• Unable to produce written informed consent after information in Norwegian